The role of ferroptosis‐related genes for overall survival prediction in breast cancer

Identification of a small molecule as inducer of ferroptosis and apoptosis through ubiquitination of GPX4 in triple negative breast cancer cells

(2021) Yahui Ding et al.   Journal of Hematology & Oncology

DDR2 upregulation confers ferroptosis susceptibility of recurrent breast tumors through the Hippo pathway

(2021) Chao-Chieh Lin et al.   ONCOGENE

Ferroptosis: past, present and future

(2020) Jie Li et al.   Cell Death & Disease

Regulation of GSK3β/Nrf2 signaling pathway modulated erastin-induced ferroptosis in breast cancer

(2020) Xinghan Wu et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Role of GPX4-Mediated Ferroptosis in the Sensitivity of Triple Negative Breast Cancer Cells to Gefitinib

(2020) Xiang Song et al.   Frontiers in Oncology

Targeting Ferroptosis to Iron Out Cancer

(2019) Behrouz Hassannia et al.   CANCER CELL

OUP accepted manuscript

(2018)   ACTA BIOCHIMICA ET BIOPHYSICA SINICA

Iron in the Tumor Microenvironment—Connecting the Dots

(2018) Christa Pfeifhofer-Obermair et al.   Frontiers in Oncology

Risk Factors and Preventions of Breast Cancer

(2017) Yi-Sheng Sun et al.   International Journal of Biological Sciences

Oxidative Stress Gene Expression Profile Correlates with Cancer Patient Poor Prognosis: Identification of Crucial Pathways Might Select Novel Therapeutic Approaches

(2017) Alessandra Leone et al.   Oxidative Medicine and Cellular Longevity

Coexpression of NOS2 and COX2 accelerates tumor growth and reduces survival in estrogen receptor-negative breast cancer

(2017) Debashree Basudhar et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Autophagy promotes ferroptosis by degradation of ferritin

(2016) Wen Hou et al.   Autophagy

Hormone Receptor/Human Epidermal Growth Factor Receptor 2-positive breast cancer: Where we are now and where we are going

(2016) Francesco Schettini et al.   CANCER TREATMENT REVIEWS

Ferroptosis is induced following siramesine and lapatinib treatment of breast cancer cells

(2016) S Ma et al.   Cell Death & Disease

Luminal B breast cancer: patterns of recurrence and clinical outcome

(2016) Zhi-hua Li et al.   Oncotarget

Erastin sensitizes glioblastoma cells to temozolomide by restraining xCT and cystathionine-γ-lyase function

(2015) LIANGYU CHEN et al.   ONCOLOGY REPORTS

The Evolving Landscape of HER2 Targeting in Breast Cancer

(2015) Mark M. Moasser et al.   JAMA Oncology

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

(2014) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Tumor microenvironment-based feed-forward regulation of NOS2 in breast cancer progression

(2014) J. L. Heinecke et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Caspase-Independent Cell Death Is Involved in the Negative Effect of EGF Receptor Inhibitors on Cisplatin in Non-Small Cell Lung Cancer Cells

(2013) H. Yamaguchi et al.   CLINICAL CANCER RESEARCH

Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death

(2012) Scott J. Dixon et al.   CELL

Comprehensive molecular portraits of human breast tumours

(2012) Daniel C. Koboldt et al.   NATURE

Increased NOS2 predicts poor survival in estrogen receptor–negative breast cancer patients

(2010) Sharon A. Glynn et al.   JOURNAL OF CLINICAL INVESTIGATION

Stimulation of Prostate Cancer Cellular Proliferation and Invasion by the Androgen Receptor Co-Activator ARA70β

(2007) Yi Peng et al.   AMERICAN JOURNAL OF PATHOLOGY